Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Erratum to "Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA)" [Am Heart J (2019) 30-34].

Decker PA, Larson NB, Bell EJ, Pankow JS, Hanson NQ, Wassel CL, Tsai MY, Bielinski SJ.

Am Heart J. 2019 Oct;216:151. doi: 10.1016/j.ahj.2019.07.001. Epub 2019 Aug 20. No abstract available.

PMID:
31439267
2.

Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

Decker PA, Larson NB, Bell EJ, Pankow JS, Hanson NQ, Wassel CL, Tsai MY, Bielinski SJ.

Am Heart J. 2019 Jul;213:30-34. doi: 10.1016/j.ahj.2019.03.018. Epub 2019 Apr 13. Erratum in: Am Heart J. 2019 Oct;216:151.

PMID:
31085382
3.

Characteristics of the National Applicant Pool for Clinical Informatics Fellowships (2016-2017).

Bell DS, Baldwin K, Bell EJ 3rd, Lehmann CU, Webber EC, Mohan V, Leu MG, Hofmann JM, Kaelber DC, Landman AB, Hron J, Silverman HD, Levy B, Elkin PL, Poon E, Luberti AA, Finnell JT, Safran C, Palma JP, Forman BH, Kileen J, Arvin D, Pfeffer M.

AMIA Annu Symp Proc. 2018 Dec 5;2018:225-231. eCollection 2018.

4.

How Patients Use a Patient Portal: An Institutional Case Study of Demographics and Usage Patterns.

Tsai R, Bell EJ 3rd, Woo H, Baldwin K, Pfeffer MA.

Appl Clin Inform. 2019 Jan;10(1):96-102. doi: 10.1055/s-0038-1677528. Epub 2019 Feb 6.

5.

Hepatocyte growth factor is associated with progression of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA).

Bell EJ, Decker PA, Tsai MY, Pankow JS, Hanson NQ, Wassel CL, Larson NB, Cohoon KP, Budoff MJ, Polak JF, Stein JH, Bielinski SJ.

Atherosclerosis. 2018 May;272:162-167. doi: 10.1016/j.atherosclerosis.2018.03.040. Epub 2018 Mar 23.

6.

CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications.

St Sauver JL, Olson JE, Roger VL, Nicholson WT, Black JL 3rd, Takahashi PY, Caraballo PJ, Bell EJ, Jacobson DJ, Larson NB, Bielinski SJ.

Pharmgenomics Pers Med. 2017 Jul 24;10:217-227. doi: 10.2147/PGPM.S136341. eCollection 2017.

7.

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.

Bielinski SJ, Berardi C, Decker PA, Larson NB, Bell EJ, Pankow JS, Sale MM, Tang W, Hanson NQ, Wassel CL, de Andrade M, Budoff MJ, Polak JF, Sicotte H, Tsai MY.

Heart. 2017 Aug;103(15):1185-1193. doi: 10.1136/heartjnl-2016-310450. Epub 2017 Jun 1.

8.

Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time).

Olson JE, Rohrer Vitek CR, Bell EJ, McGree ME, Jacobson DJ, St Sauver JL, Caraballo PJ, Griffin JM, Roger VL, Bielinski SJ.

Genet Med. 2017 Jul;19(7):819-825. doi: 10.1038/gim.2016.192. Epub 2017 Jan 5.

9.

Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?

Bielinski SJ, St Sauver JL, Olson JE, Wieland ML, Vitek CR, Bell EJ, Mc Gree ME, Jacobson DJ, McCormick JB, Takahashi PY, Black JL, Caraballo PJ, Sharp RR, Beebe TJ, Weinshilboum RM, Wang L, Roger VL.

Pharmacogenomics J. 2017 Jan;17(1):1-3. doi: 10.1038/tpj.2016.72. Epub 2016 Oct 25. No abstract available.

10.

Hepatocyte Growth Factor Is Positively Associated With Risk of Stroke: The MESA (Multi-Ethnic Study of Atherosclerosis).

Bell EJ, Larson NB, Decker PA, Pankow JS, Tsai MY, Hanson NQ, Wassel CL, Longstreth WT Jr, Bielinski SJ.

Stroke. 2016 Nov;47(11):2689-2694. Epub 2016 Oct 11.

11.

ABO blood group associations with markers of endothelial dysfunction in the Multi-Ethnic Study of Atherosclerosis.

Larson NB, Bell EJ, Decker PA, Pike M, Wassel CL, Tsai MY, Pankow JS, Tang W, Hanson NQ, Alexander K, Zakai NA, Cushman M, Bielinski SJ.

Atherosclerosis. 2016 Aug;251:422-429. doi: 10.1016/j.atherosclerosis.2016.05.049. Epub 2016 Jun 7.

12.

Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality.

St Sauver JL, Bielinski SJ, Olson JE, Bell EJ, Mc Gree ME, Jacobson DJ, McCormick JB, Caraballo PJ, Takahashi PY, Roger VL, Rohrer Vitek CR.

Am J Med. 2016 Oct;129(10):1093-1099.e1. doi: 10.1016/j.amjmed.2016.04.009. Epub 2016 May 5.

13.

The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.

Murray AM, Bell EJ, Tupper DE, Davey CS, Pederson SL, Amiot EM, Miley KM, McPherson L, Heubner BM, Gilbertson DT, Foley RN, Drawz PE, Slinin Y, Rossom RC, Lakshminarayan K, Vemuri P, Jack CR, Knopman DS.

Am J Kidney Dis. 2016 Apr;67(4):593-600. doi: 10.1053/j.ajkd.2015.11.008. Epub 2015 Dec 29.

14.

Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis.

Bell EJ, Folsom AR, Lutsey PL, Selvin E, Zakai NA, Cushman M, Alonso A.

Diabetes Res Clin Pract. 2016 Jan;111:10-8. doi: 10.1016/j.diabres.2015.10.019. Epub 2015 Nov 10. Review.

15.

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies.

Bell EJ, Lutsey PL, Basu S, Cushman M, Heckbert SR, Lloyd-Jones DM, Folsom AR.

Am J Med. 2016 Mar;129(3):339.e19-26. doi: 10.1016/j.amjmed.2015.10.014. Epub 2015 Nov 18.

16.

Developing rural community health risk assessments for climate change: a Tasmanian pilot study.

Bell EJ, Turner P, Meinke H, Holbrook NJ.

Rural Remote Health. 2015 Jul-Sep;15(3):3174. Epub 2015 Sep 22. Review.

17.

Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies.

Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL, Folsom AR.

Am J Hypertens. 2016 May;29(5):634-40. doi: 10.1093/ajh/hpv151. Epub 2015 Aug 25.

18.

Residents with mild cognitive decline and family members report health students 'enhance capacity of care' and bring 'a new breath of life' in two aged care facilities in Tasmania.

Elliott KE, Annear MJ, Bell EJ, Palmer AJ, Robinson AL.

Health Expect. 2015 Dec;18(6):1927-40. doi: 10.1111/hex.12236. Epub 2014 Jul 7.

19.

Information technology improves Emergency Department patient discharge instructions completeness and performance on a national quality measure: a quasi-experimental study.

Bell EJ, Takhar SS, Beloff JR, Schuur JD, Landman AB.

Appl Clin Inform. 2013 Oct 23;4(4):499-514. doi: 10.4338/ACI-2013-07-RA-0046. eCollection 2013.

20.

A comparative analysis of risk factors for stroke in blacks and whites: the Atherosclerosis Risk in Communities study.

Huxley RR, Bell EJ, Lutsey PL, Bushnell C, Shahar E, Rosamond W, Gottesman R, Folsom A.

Ethn Health. 2014;19(6):601-16. doi: 10.1080/13557858.2013.857765. Epub 2013 Nov 21.

21.

Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study.

Bell EJ, Selvin E, Lutsey PL, Nambi V, Cushman M, Folsom AR.

Vasc Med. 2013 Oct;18(5):245-50. doi: 10.1177/1358863X13506764.

22.

Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.

Folsom AR, Nambi V, Bell EJ, Oluleye OW, Gottesman RF, Lutsey PL, Huxley RR, Ballantyne CM.

Stroke. 2013 Apr;44(4):961-7. doi: 10.1161/STROKEAHA.111.000173. Epub 2013 Mar 7.

23.

Climate change and health research: has it served rural communities?

Bell EJ.

Rural Remote Health. 2013 Jan-Mar;13(1):2343. Epub 2013 Feb 12. Review.

24.

Physical activity and cardiovascular disease in African Americans in Atherosclerosis Risk in Communities.

Bell EJ, Lutsey PL, Windham BG, Folsom AR.

Med Sci Sports Exerc. 2013 May;45(5):901-7. doi: 10.1249/MSS.0b013e31827d87ec.

25.

Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis.

Wattanakit K, Lutsey PL, Bell EJ, Gornik H, Cushman M, Heckbert SR, Rosamond WD, Folsom AR.

Thromb Haemost. 2012 Sep;108(3):508-15. doi: 10.1160/TH11-10-0726. Epub 2012 Jul 10.

26.

Climate change: what competencies and which medical education and training approaches?

Bell EJ.

BMC Med Educ. 2010 Apr 30;10:31. doi: 10.1186/1472-6920-10-31.

27.

'Lost in translation'? Developing assessment criteria that value rural practice.

Bell EJ, MacCarrick G, Parker L, Allen R.

Rural Remote Health. 2005 Jul-Sep;5(3):420. Epub 2005 Jul 22.

28.

Tooth wear in children with Down syndrome.

Bell EJ, Kaidonis J, Townsend GC.

Aust Dent J. 2002 Mar;47(1):30-5.

29.

Influence of a financial incentive on cognitive services: CARE project design/implementation.

Christensen DB, Holmes G, Fassett WE, Neil N, Andrilla CH, Smith DH, Andrews A, Bell EJ, Hansen RW, Shafer R, Stergachis A.

J Am Pharm Assoc (Wash). 1999 Sep-Oct;39(5):629-39.

PMID:
10533344
30.

Comparison of exposed dentinal surfaces resulting from abrasion and erosion.

Bell EJ, Kaidonis J, Townsend G, Richards L.

Aust Dent J. 1998 Oct;43(5):362-6.

31.

Principal findings from the Washington State cognitive services demonstration project.

Christensen DB, Holmes G, Fassett WE, Neil N, Andrilla CH, Smith DH, Andrews A, Bell EJ, Hansen R, Shafer R, Stergachis A.

Manag Care Interface. 1998 Jul;11(7):60-2, 64.

PMID:
10181572
32.

Replication-competent retroviral vectors for expressing genes in avian cells in vitro and in vivo.

Bell EJ, Brickell PM.

Mol Biotechnol. 1997 Jun;7(3):289-98. Review.

PMID:
9219242
33.

Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb.

Duprez D, Bell EJ, Richardson MK, Archer CW, Wolpert L, Brickell PM, Francis-West PH.

Mech Dev. 1996 Jul;57(2):145-57.

34.

Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome.

Miller NA, Carmichael HA, Calder BD, Behan PO, Bell EJ, McCartney RA, Hall FC.

BMJ. 1991 Jan 19;302(6769):140-3.

35.

Myalgic encephalomyelitis--a persistent enteroviral infection?

Dowsett EG, Ramsay AM, McCartney RA, Bell EJ.

Postgrad Med J. 1990 Jul;66(777):526-30.

36.

A cumulative review of studies on travellers, their experience of illness and the implications of these findings.

Cossar JH, Reid D, Fallon RJ, Bell EJ, Riding MH, Follett EA, Dow BC, Mitchell S, Grist NR.

J Infect. 1990 Jul;21(1):27-42. Review.

PMID:
2166766
37.

Fatal outcome of echovirus 7 infection.

Ho-Yen DO, Hardie R, McClure J, Cunningham NE, Bell EJ.

Scand J Infect Dis. 1989;21(4):459-61.

PMID:
2587948
38.

Features of Coxsackie B virus (CBV) infection in children with prolonged physical and psychological morbidity.

Wilson PM, Kusumakar V, McCartney RA, Bell EJ.

J Psychosom Res. 1989;33(1):29-36.

PMID:
2538617
39.

A splint in time.

Bell EJ.

Prof Nurse. 1988 Aug;3(11):464-5. No abstract available.

PMID:
3420124
40.

Vaccine-induced polioencephalomyelitis in Scotland.

Asindi AA, Bell EJ, Browning MJ, Stephenson JB.

Scott Med J. 1988 Aug;33(4):306-7.

PMID:
2847313
41.

Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase.

Archard LC, Bowles NE, Behan PO, Bell EJ, Doyle D.

J R Soc Med. 1988 Jun;81(6):326-9.

42.

Coxsackie B viruses and myalgic encephalomyelitis.

Bell EJ, McCartney RA, Riding MH.

J R Soc Med. 1988 Jun;81(6):329-31.

43.

Non-polio enteroviruses and motor neurone disease.

Kennedy PG, Bell EJ, Keane SA, Timbury MC.

J Clin Pathol. 1988 May;41(5):596-7. No abstract available.

44.

Chronic enterovirus infection in patients with postviral fatigue syndrome.

Yousef GE, Bell EJ, Mann GF, Murugesan V, Smith DG, McCartney RA, Mowbray JF.

Lancet. 1988 Jan 23;1(8578):146-50.

PMID:
2892990
45.

Coxsackie B viruses and the post viral syndrome in nuclear submariners.

Warnock PJ, Bell EJ, Riding MH.

J R Nav Med Serv. 1988 Summer;74(2):95-9. No abstract available.

PMID:
2855744
46.

Coxsackie B viruses and the post-viral syndrome: a prospective study in general practice.

Calder BD, Warnock PJ, McCartney RA, Bell EJ.

J R Coll Gen Pract. 1987 Jan;37(294):11-4.

47.

Fatal Coxsackie B meningoencephalitis diagnosed by serology and in-situ nucleic acid hybridisation.

Hallam NF, Eglin RP, Holland P, Bell EJ, Squier MV.

Lancet. 1986 Nov 22;2(8517):1213-4. No abstract available.

PMID:
2877342
48.

Paralytic poliomyelitis: a forgotten diagnosis?

Bell EJ, Riding MH, Grist NR.

Br Med J (Clin Res Ed). 1986 Jul 19;293(6540):193-4. No abstract available.

49.

Mu-antibody capture ELISA for the rapid diagnosis of enterovirus infections in patients with aseptic meningitis.

Bell EJ, McCartney RA, Basquill D, Chaudhuri AK.

J Med Virol. 1986 Jul;19(3):213-7.

PMID:
3016164
50.

Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections.

McCartney RA, Banatvala JE, Bell EJ.

J Med Virol. 1986 Jul;19(3):205-12.

PMID:
3016163

Supplemental Content

Support Center